본문 바로가기
KERD
논문KCI 등재

A neutrophil elastase-generated mature form of IL-33 is a potent regulator of endothelial cell activation and proliferative retinopathy

Bisen Shivantika|Verma Shailendra Kumar|Mukhopadhyay Chandra Sekhar|Singh Nikhlesh K.
생화학분자생물학회 (Korean Society Of Biochemistry And Molecular Biology)|2024.12|Experimental and Molecular Medicine|제56권 |pp. 1703-1716|DOI 10.1038/s12276-024-01279-y

0

조회

0

다운로드

0

인용

0

참고문헌

주제분류생화학

초록

Human interleukin-33 (IL-33) is a 270 amino acid protein that belongs to the IL-1 cytokine family and plays an important role in various inflammatory disorders. Neutrophil proteases (Cathepsin G and Elastase) and mast cell proteases (tryptase and chymase) regulate the activity of IL-33 by processing full-length IL-33 into its mature form. There is little evidence on the role of these mature forms of IL-33 in retinal endothelial cell signaling and pathological retinal angiogenesis. Here, we cloned, expressed, and purified the various mature forms of human IL-33 and then evaluated the effects of IL-3395-270, IL-3399-270, IL-33109-270, and IL-33112-270 on angiogenesis in human retinal microvascular endothelial cells (HRMVECs). We observed that IL-3395-270, IL-3399-270, IL-33109-270, and IL-33112-270 significantly induced HRMVEC migration, tube formation and sprouting angiogenesis. However, only IL-3399-270 could induce HRMVEC proliferation. We used a murine model of oxygen-induced retinopathy (OIR) to assess the role of these mature forms of IL-33 in pathological retinal neovascularization. Our 3′-mRNA sequencing and signaling studies indicated that IL-3399-270 and IL-33109-270 were more potent at inducing endothelial cell activation and angiogenesis than the other mature forms. We found that genetic deletion of IL-33 significantly reduced OIR-induced retinal neovascularization in the mouse retina and that intraperitoneal administration of mature forms of IL-33, mainly IL-3399–270 and IL-33109–270, significantly restored ischemia-induced angiogenic sprouting and tuft formation in the hypoxic retinas of IL-33–/– mice. Thus, our study results suggest that blockade or inhibition of IL-33 cleavage by neutrophil proteases could help mitigate pathological angiogenesis in proliferative retinopathies.

Abstract

Human interleukin-33 (IL-33) is a 270 amino acid protein that belongs to the IL-1 cytokine family and plays an important role in various inflammatory disorders. Neutrophil proteases (Cathepsin G and Elastase) and mast cell proteases (tryptase and chymase) regulate the activity of IL-33 by processing full-length IL-33 into its mature form. There is little evidence on the role of these mature forms of IL-33 in retinal endothelial cell signaling and pathological retinal angiogenesis. Here, we cloned, expressed, and purified the various mature forms of human IL-33 and then evaluated the effects of IL-3395-270, IL-3399-270, IL-33109-270, and IL-33112-270 on angiogenesis in human retinal microvascular endothelial cells (HRMVECs). We observed that IL-3395-270, IL-3399-270, IL-33109-270, and IL-33112-270 significantly induced HRMVEC migration, tube formation and sprouting angiogenesis. However, only IL-3399-270 could induce HRMVEC proliferation. We used a murine model of oxygen-induced retinopathy (OIR) to assess the role of these mature forms of IL-33 in pathological retinal neovascularization. Our 3′-mRNA sequencing and signaling studies indicated that IL-3399-270 and IL-33109-270 were more potent at inducing endothelial cell activation and angiogenesis than the other mature forms. We found that genetic deletion of IL-33 significantly reduced OIR-induced retinal neovascularization in the mouse retina and that intraperitoneal administration of mature forms of IL-33, mainly IL-3399–270 and IL-33109–270, significantly restored ischemia-induced angiogenic sprouting and tuft formation in the hypoxic retinas of IL-33–/– mice. Thus, our study results suggest that blockade or inhibition of IL-33 cleavage by neutrophil proteases could help mitigate pathological angiogenesis in proliferative retinopathies.

참고문헌 (49)

  1. Garlanda, C., "The interleukin-1 family: back to the future", Immunity, 39, pp.1003~1018 (2013)
  2. Cayrol, C., "The IL-1-like cytokine IL-33 is inactivated after maturation by caspase-1", Proc. Natl Acad. Sci. USA, 106, pp.9021~9026 (2009)
  3. Schmitz, J., "IL-33, an interleukin-1-like cytokine that signals via the IL-1receptor-related protein ST2 and induces T helper type 2-associated cytokines", Immunity, 23, pp.479~490 (2005)
  4. Liew, F. Y., "Disease-associated functions of IL-33 : the new kid in the IL-1 family", Nat. Rev. Immunol, 10, pp.103~110 (2010)
  5. Choi, Y. S., "Interleukin-33 induces angiogenesis and vascular permeability through ST2", TRAF6-mediated endothelial nitric oxide production, 2009, pp.114, 3117~3126
  6. Sharma, D., "IL-33 enhances Jagged1 mediated NOTCH1 intracellular domain(NICD)deubiquitination and pathological angiogenesis in proliferative retino pathy", Commun. Biol, 5, pp.479~ (2022)
  7. Kaur, G., "Vascular cell-adhesion molecule 1(VCAM-1)regulates JunB mediated IL-8", CXCL1 expression and pathological neovascularization, 2023, pp.6, 516~
  8. Sharma, D., "IL-33 via PKCμ", PRKD1 mediated α-catenin phosphorylation regulates endothelial cell-barrier integrity and ischemia-induced vascular leak age, 2023, pp.12, 703~
  9. Shan, S., "Nasal administration of interleukin-33 induces airways angiogenesis and expression of multiple angiogenic factors in a murine asthma surrogate", Immunology, 148, pp.83~91 (2016)
  10. He, R., "IL-33 improves wound healing through enhanced M2 macrophage polarization in diabetic mice", Mol. Immunol, 90, pp.42~49 (2017)
  11. Liu, J., "IL-33 initiates vascular remodelling in hypoxic pulmonary hyperten sion by up-regulating HIF-1α and VEGF expression in vascular endothelial cells", EBioMedicine, 33, pp.196~210 (2018)
  12. Theodoropoulou, S., "Interleukin-33 regulates tissue remodelling and inhibits angiogenesis in the eye", J. Pathol, 241, pp.45~56 (2017)
  13. Baekkevold, E. S., "Molecular characterization of NF-HEV, a nuclear factor preferentially expressed in human high endothelial venules", Am. J. Pathol, 163, pp.69~79 (2003)
  14. Carriere, V., "IL-33, the IL-1-like cytokine ligand for ST2 receptor, is a chromatin-associated nuclear factor in vivo", Proc. Natl Acad. Sci. USA, 104, pp.282~287 (2007)
  15. Roussel, L., "Molecular mimicry between IL-33and KSHV for attachment to chromatin through the H2A-H2B acidic pocket", EMBO Rep, 9, pp.1006~1012 (2008)
  16. Luthi, A. U., "Suppression of interleukin-33 bioactivity through proteolysis by apoptotic caspases", Immunity, 31, pp.84~98 (2009)
  17. Talabot-Ayer, D., "Interleukin-33 is biologi cally active independently of caspase-1 cleavage", J. Biol. Chem, 284, pp.19420~19426 (2009)
  18. Ali, S., "Caspase 3 inactivates biologically active full-length interleukin-33 as a classical cytokine but does not prohibit nuclear translocation", Biochem. Biophys. Res. Commun, 391, pp.1512~1516 (2010)
  19. Lefrançais, E., "IL-33 is processed into mature bioactive forms by neutrophil elastase and cathepsin G", Proc. Natl Acad. Sci. USA, 109, pp.1673~1678 (2012)
  20. Lefrançais, E., "Central domain of IL-33 is cleaved by mast cell proteases for potent activation of group-2 innate lymphoid cells", Proc. Natl Acad. Sci. USA, 111, pp.15502~15507 (2014)
  21. Arend, W. P., "IL-1, IL-18, and IL-33 families of cytokines", Immunol. Rev, 223, pp.20~38 (2008)
  22. Sanada, S., "IL-33 and ST2 comprise a critical biomechanically induced and cardioprotective signaling system", J. Clin. Invest, 117, pp.1538~1549 (2007)
  23. Hsu, C. L., "Allergic inflammation is initiated by IL-33-dependent crosstalk between mast cells and basophils", PLoS ONE, 15, pp.e0226701~ (2020)
  24. Lakso, M., "Efficient in vivo manipulation of mouse genomic sequences at the zygote stage", Proc. Natl Acad. Sci. USA, 93, pp.5860~5865 (1996)
  25. Singh, N. K., "Cyclic AMP response element binding protein mediates pathological retinal neovascularization via modulating DLL4NOTCH1 signaling", EBioMedicine, 2, pp.1767~1784 (2015)
  26. Roy, B., "Aldehyde dehydrogenase 2 augments adiponectin signaling in coronary angiogenesis in HFpEF associated with diabetes", FASEB J, 36, pp.e22440~ (2022)
  27. Smith, L. E., "Oxygen-induced retinopathy in the mouse", Invest. Ophthalmol. Vis. Sci, 35, pp.101~111 (1994)
  28. Connor, K. M., "Quantification of oxygen-induced retinopathy in the mouse : a model of vessel loss, vessel regrowth and pathological angiogenesis", Nat. Protoc, 4, pp.1565~1573 (2009)
  29. Langfelder, P., "WGCNA : an R package for weighted correlation network analysis", BMC Bioinformatics, 9, pp.559~ (2008)
  30. "Heatmaps for gene expression" (2015)[URL]
  31. Cargnello, M., "Activation and function of the MAPKs and their substrates, the MAPK-activated protein kinases", Microbiol. Mol. Biol. Rev, 75, pp.50~83 (2011)
  32. Kofler, N. M., "Notch signaling in developmental and tumor angiogenesis", Genes Cancer, 2, pp.1106~1116 (2011)
  33. Lu, P., "Extracellular matrix degradation and remodeling in development and disease", Cold Spring Harb. Perspect. Biol, 3, pp.a005058~ (2011)
  34. Sharma, D., "The biochemistry and physiology of a disintegrin and metalloproteinases(ADAMs and ADAM-TSs)in human pathologies", Rev. Physiol. Biochem. Pharmacol, 184, pp.69~120 (2023)
  35. Morales, J., "Homozygous mutations in ADAMTS10 and ADAMTS17 cause lenticular myopia, ectopia lentis, glaucoma, spherophakia, and short stature", Am. J. Hum. Genet, 85, pp.558~568 (2009)
  36. Beránek, M., "Genetic variations and plasma levels of gelatinase A(matrix metalloproteinase-2)and gelatinase B(matrix metalloproteinase-9)in proliferative diabetic retinopathy", Mol. Vis, 14, pp.1114~1121 (2008)
  37. Moussion, C., "The IL-1-like cytokine IL-33 is constitutively expressed in the nucleus of endothelial cells and epithelial cells in vivo: a novel ‘alarmin’?", PLoS ONE, 3, pp.e3331~ (2008)
  38. Lamkanfi, M., "IL-33 raises alarm", Immunity, 31, pp.5~7 (2009)
  39. Cayrol, C., "Environmental allergens induce allergic inflammation through proteolytic maturation of IL-33", Nat. Immunol, 19, pp.375~385 (2018)
  40. Cayrol, C., "Interleukin-33(IL-33) : a nuclear cytokine from the IL-1family", Immunol. Rev, 281, pp.154~168 (2018)
  41. Chen, C. J., "Identification of a key pathway required for the sterile inflam matory response triggered by dying cells", Nat. Med, 13, pp.851~856 (2007)
  42. Verri, W. A. Jr, "IL-33 induces neutrophil migration in rheumatoid arthritis and is a target of anti-TNF therapy", Ann. Rheum. Dis, 69, pp.1697~1703 (2010)
  43. Xu, D., "IL-33 exacerbates antigen-induced arthritis by activating mast cells", Proc. Natl Acad. Sci. USA, 105, pp.10913~10918 (2008)
  44. Palmer, G., "Inhibition of interleukin-33 signaling attenuates the severity of experimental arthritis", Arthritis Rheum, 60, pp.738~749 (2009)
  45. Liew, F. Y., "Interleukin-33 in health and disease", Nat. Rev. Immunol, 16, pp.676~689 (2016)
  46. Funakoshi-Tago, M., "TRAF6 is a critical signal transducer in IL-33 signaling pathway", Cell Signal, 20, pp.1679~1686 (2008)
  47. Ali, S., "IL-1 receptor accessory protein is essential for IL-33-induced activation of T lymphocytes and mast cells", Proc. Natl Acad. Sci. USA, 104, pp.18660~18665 (2007)
  48. Chackerian, A. A., "IL-1 receptor accessory protein and ST2 comprise the IL-33receptor complex", J. Immunol, 179, pp.2551~2555 (2007)
  49. Cao, K., "IL-33", ST2 plays a critical role in endothelial cell activation and microglia-mediated neuroinflammation modulation, 2018, pp.15, 136~

관련 논문AI추천

Interleukin-33 and Mast Cells Bridge Innate and Adaptive Immunity: From the Allergologist’s Perspective김영효, 장태영대한배뇨장애요실금학회 · International Neurourology Journal2015 · 제19권 제3호Unlocking IL-33: New Insights into Tumor Immunity강병훈, 이흥규대한면역학회 · Immune Network2025 · 제25권 제5호Identification of specifically activated angiogenic molecules in HMGB-1-induced angiogenesis권유진, 권자영, 김원규, 김호근, 박민희, 윤승주생화학분자생물학회 · BMB Reports2017 · 제50권 제11호IL-33 Priming Enhances Peritoneal Macrophage Activity in Response to Candida albicans권병석, Hong R. Cho, Vuvi G. Tran대한면역학회 · Immune Network2014 · 제14권 제4호IL-33 and IL-33-derived DC-based tumor immunotherapyBae Yong-Soo, Kang Myeong-Ho생화학분자생물학회 · Experimental and Molecular Medicine2024 · 제56권 IL33-induced neutrophil extracellular traps (NETs) mediate a positive feedback loop for synovial inflammation and NET amplification in rheumatoid arthritisGao Huali, Jiang Renquan, Lin Jinpiao, Sheng Huiming, Tang Jifeng, Xia Jinfang, Xiao Lianbo생화학분자생물학회 · Experimental and Molecular Medicine2024 · 제56권

이 간행물의 다른 논문 (218건)

Big data and deep learning for RNA biologyJeon Hyeonseong, Baek Daehyun, Hwang Hyeonseo, Yeo Nagyeongpp. 1-29RGS19 activates the MYH9/β-catenin/c-Myc positive feedback loop in hepatocellular carcinomaXu Yanan, Ke Shanjia, Lu Shounan, Bai Miaoyu, Yu Hongjun, Yin Bing, Wang Chaoqun, Feng Zhigang, Li Zihao, Huang Jingjing, Li Xinglong, Qian Baolin, Hua Yongliang, Fu Yao, Sun Bei, Wu Yaohua, Ma Yongpp. 1-14Molecular mechanisms of circular RNA translationKim Yoon Ki, Hwang Hyun Jungpp. 1-9The m6A writer RBM15 drives the growth of triple-negative breast cancer cells through the stimulation of serine and glycine metabolismKim Ho, Yun Hye Jin, 이종호, Lee Su Bin, Kim Seok-Ho, Park Yun-Yong, Park Su Hwan, Ju Jin-Sung, Woo Hyunmin, Győrffy Balázs, Kim Eun-jeong, Han Hee Dong, Eyun Seong-ilpp. 1-15Neuron type-specific optogenetic stimulation for differential stroke recovery in chronic capsular infarctKim Ra Gyung, Cho Jongwook, Park Ji-Young, Kim Young Ro, Lee Min-Cheol, Kim Hyoung-Ihlpp. 1-11
원문 보기